Nextcure Inc
Research Nextcure Inc (NXTC) on Bullrun: market cap USD 24.05M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerNXTC
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 24.05M
- Financial periodQ2 2026
- RevenueUSD 0
- Net income-USD 14.89M
- Free cash flow-USD 9.72M
Valuation Snapshot
latest market cap is USD 24.05M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 0 | -USD 55.84M | -USD 49.61M | n/a | -19.65 | USD 25.98M | USD 5.15M | USD 34.94M |
| FY2024 | USD 0 | -USD 55.65M | -USD 41.28M | n/a | -23.88 | USD 27.73M | USD 5.95M | USD 65.47M |
| FY2023 | n/a | -USD 62.72M | -USD 53.79M | n/a | -2.25 | USD 13.08M | USD 6.61M | USD 114.42M |
| FY2022 | n/a | -USD 74.73M | -USD 56.00M | n/a | -2.69 | USD 26.63M | USD 0 | USD 167.53M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 24.05M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 37.97M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 21.59M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 31.81M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 39.16M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 166.08M | n/a | n/a | n/a |
About Nextcure Inc
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in advancing medicines to treat cancer. The company's product candidate is the LNCB74, a B7-H4 targeted ADC to kill tumors. It also develops NC410, a fusion protein of LAIR-2, that is designed to block immune suppression mediated by LAIR-1; NC525, a novel LAIR-1 antibody that targets acute myeloid leukemia, blast cells, and leukemic stem cells; NC181 a humanized antibody targeting ApoE4 for the treatment of Alzheimer's disease;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Nextcure Inc's market cap?
Nextcure Inc's market capitalization is USD 24.05M.
What does Nextcure Inc do?
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in advancing medicines to treat cancer. The company's product candidate is the LNCB74, a B7-H4 targeted ADC to kill tumors.